- Home
- IFRX vs LCUT Comparison
IFRX vs LCUT Comparison
Compare IFRX & LCUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- LCUT
- Stock Information
- Founded
- IFRX 2007
- LCUT 1945
- Country
- IFRX Germany
- LCUT United States
- Employees
- IFRX N/A
- LCUT N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- LCUT Industrial Machinery/Components
- Sector
- IFRX Health Care
- LCUT Consumer Discretionary
- Exchange
- IFRX Nasdaq
- LCUT Nasdaq
- Market Cap
- IFRX 65.8M
- LCUT 73.7M
- IPO Year
- IFRX 2017
- LCUT 1991
- Fundamental
- Price
- IFRX $1.69
- LCUT $3.28
- Analyst Decision
- IFRX Strong Buy
- LCUT Buy
- Analyst Count
- IFRX 4
- LCUT 2
- Target Price
- IFRX $8.50
- LCUT $5.50
- AVG Volume (30 Days)
- IFRX 262.5K
- LCUT 90.4K
- Earning Date
- IFRX 05-07-2025
- LCUT 05-08-2025
- Dividend Yield
- IFRX N/A
- LCUT 5.17%
- EPS Growth
- IFRX N/A
- LCUT N/A
- EPS
- IFRX N/A
- LCUT N/A
- Revenue
- IFRX $140,242.00
- LCUT $680,795,000.00
- Revenue This Year
- IFRX $61.96
- LCUT $2.06
- Revenue Next Year
- IFRX $80.59
- LCUT $2.49
- P/E Ratio
- IFRX N/A
- LCUT N/A
- Revenue Growth
- IFRX 30.90
- LCUT N/A
- 52 Week Low
- IFRX $0.82
- LCUT $3.12
- 52 Week High
- IFRX $2.82
- LCUT $11.68
- Technical
- Relative Strength Index (RSI)
- IFRX 62.40
- LCUT 39.38
- Support Level
- IFRX $1.53
- LCUT $2.89
- Resistance Level
- IFRX $1.92
- LCUT $3.82
- Average True Range (ATR)
- IFRX 0.19
- LCUT 0.29
- MACD
- IFRX 0.02
- LCUT 0.04
- Stochastic Oscillator
- IFRX 74.59
- LCUT 41.94
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About LCUT Lifetime Brands Inc.
Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.